Autopsy report · NCT00748566
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Cause of deathNo reason given
“See Detailed Description”
Life of this trial
- Registered 3 months before it started.
- Ran for about 3 years 5 months before it stopped.
- 172 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Industry
- Conditions
- Schizophrenia and Disorders With Psychotic Features
- Interventions
- Ziprasidone HCL (oral)
- Participants
- 172
- Sites
- 32
- Countries
- Canada
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.